Document:AXA/2025/FY/Earnings release: Difference between revisions

Content deleted Content added
doc_archive: publish chq99br5nr (original transcript) (.md link)
doc_archive: rerender chq99br5nr (renderer update)
Line 11:
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf
| wide = yes
| original_md = File:AXA<!-2025-FY ARCHIVE_MD_LINK_HERE -Earnings_release-original.md>
| docling_file = File:AXA<!-2025-FY ARCHIVE_DOCLING_LINK_HERE -Earnings_release-docling.txt>
| article = AXA/2025/FY/Earnings release
| doc_id = chq99br5nr
Line 79:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a reported basis
! class="col-s" style="text-align:right" | Change at comparable basis
|-
| style="text-align:left" | Gross written premiums &amp; other revenues{{fn ref|1}}
Line 114:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a reported basis
! class="col-s" style="text-align:right" | Change at constant Forex
|-
| style="text-align:left" | Underlying earnings{{fn ref|2}}
Line 137:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a reported basis
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Solvency II ratio (%){{fn ref|5}}
Line 215:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a comparable basis
! class="col-s" style="text-align:right" | FY25 Price effect{{fn ref|12}} (in %)
|-
| style="text-align:left" | Gross written premiums and other revenues
Line 251:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant Forex
|-
| style="text-align:left" | All-Year Combined ratio
Line 308:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a comparable basis
|-
| style="text-align:left" | Gross written premiums &amp; other revenues
Line 359:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant forex
|-
| style="text-align:left" | Underlying earnings
Line 520:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | USD
Line 658:
|-
! style="text-align:left" | in Euro million
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a reported basis
! class="col-s" style="text-align:right" | Change on a comparable basis
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a comparable basis
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a comparable basis
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change on a comparable basis
|-
| style="text-align:left" | France{{fn ref|i|2=Including Banking revenues amounting to Euro 99 million in FY25 and Euro 118 million in FY24.}}
Line 770:
|-
! style="text-align:left" | in Euro million
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant Forex
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant Forex
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant Forex
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant Forex
|-
| style="text-align:left" | France
Line 874:
|-
! style="text-align:left" | in Euro million
! class="col-s" style="text-align:right" | Total Commercial
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! class="col-s" style="text-align:right" | Personal Motor
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! class="col-s" style="text-align:right" | Personal Non-Motor
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! class="col-s" style="text-align:right" | Total Personal
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! class="col-s" style="text-align:right" | Total Reinsurance
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
|-
| style="text-align:left" | France
Line 980:
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! class="col-s" style="text-align:right" | FY25{{fn ref|ii|2=Average of monthly opening discount rates of 2025}}
|-
| style="text-align:left" | EUR
Line 1,110:
|-
! style="text-align:left" | in Euro million
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change{{fn ref|i|2=Changes are at comparable basis (constant forex, scope and methodology)}}
|-
| style="text-align:left" | France
Line 1,221:
|-
! style="text-align:left" | in Euro million
! class="col-s" style="text-align:right" | PVEP
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | NBV
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | NBV margin
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | PVEP
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | NBV
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | NBV margin
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | PVEP
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | NBV
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
! class="col-s" style="text-align:right" | NBV margin
! class="col-s" style="text-align:right" | Change{{fn ref|ii|2=Changes are at comparable basis (constant forex, scope and methodology)}}
|-
| style="text-align:left" | France
Line 1,328:
|-
! style="text-align:left" | in Euro million
! class="col-s" style="text-align:right" | Life
! class="col-s" style="text-align:right" | Health{{fn ref|i|2=Includes Health business written predominantly in Life entities}}
! class="col-s" style="text-align:right" | Total{{fn ref|i|2=Includes Health business written predominantly in Life entities}}
|-
| style="text-align:left" | NB CSM (pre-tax)
Line 1,365:
|-
! style="text-align:left" | in Euro billion
! class="col-m" style="text-align:right" | FY24
! class="col-m" style="text-align:right" | FY25
|-
| style="text-align:left" | Health{{fn ref|i|2=Includes Health business written predominantly in Life entities}}